Skip to main content
Asia-Pacific Journal of Oncology Nursing logoLink to Asia-Pacific Journal of Oncology Nursing
. 2024 Feb 10;11(4):100402. doi: 10.1016/j.apjon.2024.100402

Screening behaviors of high-risk individuals for lung cancer: A cross-sectional study

Yu-An Lin a,b,#, Xiujing Lin b,#, Yonglin Li b, Fangfang Wang b, Rachel Arbing d, Weiti Chen d, Feifei Huang b,c,
PMCID: PMC10944110  PMID: 38495639

Abstract

Objective

To investigate current screening behaviors among high-risk individuals and analyse the factors that influence them.

Methods

A cross-sectional of 1652 high-risk individuals were recruited in Fujian Province, China from February to October 2022. Socio-demographic characteristics of participants were collected and other survey measures included a lung cancer and lung cancer screening knowledge questionnaire and a stage of adoption algorithm. Standardized measures on surveys were comprised of the: Lung Cancer Screening Health Belief Scales, Cataldo Lung Cancer Stigma Scale, Generalized Anxiety Disorder Scale-7, Patient Health Questionnaire-9, and the Patient Trust in the Medical Profession Scale. Factors associated with screening behavior were identified using binary logistic regression analysis.

Results

Lung cancer screening behavior stages were largely reported as Stage 1 and Stage 2 (64.4%). The facilitators of lung cancer screening included urban residence (OR = 1.717, 95% CI: 1.224–2.408), holding administrative positions (OR = 16.601, 95% CI: 2.118–130.126), previous lung cancer screening behavior (OR = 10.331, 95% CI: 7.463–14.302), media exposure focused on lung cancer screening (OR = 1.868, 95% CI: 1.344–2.596), a high level of knowledge about lung cancer and lung cancer screening (OR = 1.256, 95% CI: 1.185–1.332), perceived risk of lung cancer (OR = 1.123, 95% CI: 1.029–1.225) and lung cancer screening health beliefs (OR = 1.090, 95% CI: 1.067–1.113). A barrier to lung cancer screening was found to be social influence (influence of friends or family) (OR = 0.669, 95% CI: 0.465–0.964).

Conclusions

This study found a low participation rate in lung cancer screening and identified eight factors that affected lung cancer screening behaviors among high-risk individuals. Findings suggest targeted lung cancer screening programs should be developed based on identified influencing factors in order to effectively promote awareness and uptake of lung cancer screening.

Keywords: Cancer screening, Early detection of cancer, Health behavior, Influencing factor, Lung cancer

Introduction

Lung cancer ranks as the second most common cancer in the world, with approximately 2.2 million new cases and 1.8 million deaths in 2020.1 In 2020, lung cancer became the primary cause of death in China, with 0.82 million new cases and 0.72 million fatalities.2 With most patients diagnosed at an advanced stage, poor prognoses and high recurrence rates have resulted. For those fortunate enough to be diagnosed at an early stage of lung cancer, the 5-year survival rate can be as high as 60%–70%.3 The key to reducing mortality lies in enhancing early diagnosis and treatment of lung cancer.3

Low-dose computed tomography (LDCT) is widely recognized as one of the primary methods for lung cancer screening (LCS).4 LDCT has proven to be more effective than chest X-rays in detecting lung cancer at an early stage, leading to a remarkable 20% reduction in lung cancer mortality.5 Similarly, a multicenter prospective cohort study conducted in China confirmed the benefits of LDCT for high-risk individuals, showing that a single LDCT screening could reduce lung cancer mortality by 31% during the follow-up period.6 These findings make it evident that LCS plays a crucial role in improving the health outcomes of individuals at-risk.

Despite its established effectiveness, the global adoption of LCS remains very low. For instance, in the United States, the proportion of eligible individuals receiving LCS has remained consistently low, ranging from 3.3% in 2010 to 3.9% in 2015.7 A recent study reports that less than 5% of all eligible individuals have undergone LCS.8

In China, a cancer screening project in rural and urban areas of China started in 2009 and 2012, respectively, and was designed to offer more than 210,000 individual cost-free baseline LDCT screenings.9 However, compliance with LDCT screening among high-risk groups for lung cancer has remained poor. An analysis conducted across 38 cities in China between 2017 and 2020 revealed that the majority of participants (21.25%) were high-risk individuals aged between 40 and 74 years, while the overall screening participation rate stood at only 35.32%.10 Wen Yan et al.,11 conducted an analysis on the compliance of LDCT screening in three Chinese provinces from 2017 to 2018, indicating an overall screening participation rate of 34.86% among 17,983 high-risk individuals for lung cancer. Additionally, LDCT uptake in China remained stagnant, with an overall participation rate of 33% between 2013 and 2018.12

Adhering to the principle of preventing and strengthening early cancer screening and detection is an important measure for cancer prevention and control in China. Considering the goals set forth by the Healthy China Initiative (2019–2030), which aims to achieve an early diagnosis rate of over 55% for key cancer types in high-risk areas,13 it becomes vital to focus on improving LCS behaviors of high-risk individuals.

Thus, researchers have directed their attention toward finding ways to encourage higher participation rates among those at risk. Over recent years, there has been a surge in national and international efforts dedicated to improving the implementation of LCS programs. A pivotal focus of cancer prevention and control research involves delving into the factors influencing individual screening behaviors. These factors serve as a framework to craft interventions that boost motivation for proactive screening and heighten screening awareness. This understanding not only aids in augmenting screening behaviors among high-risk individuals, but also contributes significantly toward elevating the rates of early lung cancer diagnosis and subsequent treatment.

Previous evidence suggests that the influencing factors of LCS behaviors are determined by several features, including level of health beliefs, knowledge of lung cancer and LCS, health care provider recommendations, demographic and health factors (e.g., age, gender, smoking status and economic level, etc.), as well as psychological and socio-environmental variables (e.g., mistrust, worry, social influence and media exposure, etc.).14, 15, 16, 17 However, these studies differ in key aspects that affect their interpretation, such as large sample size differences (ranging from 23 to 1730),15, 16, 17 inconsistent lung cancer risk (including average-risk individuals),17 inconsistent study methodology (mixed studies),14 and different definitions of high-risk individuals for lung cancer (LCS guidelines vary by country),15, 16, 17, 18 and such methodological differences result in inconsistent research outcomes.13, 14, 15, 16 Moreover, while these studies predominantly focus on the United States, it is important to note that culture significantly influences individual preferences regarding health-related decisions. For instance, in China, going to the hospital or discussing illness is considered taboo.

Considering the limitations of previous studies, more studies are needed into the factors that influence LCS behaviors in high-risk individuals in China. Therefore, the aim of this study is to investigate the current status of LCS behaviors and explore the factors that affect them. The selection of influencing factors to examine in this study was based on a literature review and tenets of the Health Belief Model. Factors encompassed psychological, demographic and health factors, cognitive factors, medical staff recommendations, as well as socio-environmental factors.14,15

Methods

Study design and participants

From February to October 2022, we conducted a large-scale cross-sectional study in Fuzhou and Putian cities of Fujian Province, China. To ensure a comprehensive approach to recruitment, we employed a variety of community-based methods. In each city, six neighborhoods were randomly selected as investigational sites. Throughout the study, we established strong and trusted relationships with community partners, which included medical clinics, community hospitals, and large, non-governmental organizations. Through a combination of community outreach efforts and engagement with health care providers at each investigational site, we successfully recruited 1652 high-risk individuals for inclusion in the study. Adhering to established guidelines, our study followed the principles outlined in the Strengthening the Reporting of Observational Studies in Epidemiology statement.19

The eligibility criteria for this study were based on the China Guideline for the Screening and Early Detection of Lung Cancer (2021, Beijing),18 and thus, eligible participants met the accepted definition in China of “high-risk” for lung cancer. The following study inclusion criteria were applied to participants: (1) aged between 50 and 74 years (the age range is consistent with the guidelines); (2) had at least one risk factor as defined as a) smoking history of ≥ 30 packs per year, including those who had smoked ≥ 30 packs per year but quit ≤ 15 years, b) second-hand smoke exposure (living or working with smokers for ≥ 20 years), c) diagnosis of chronic obstructive pulmonary disease, d) occupational exposure of at least 1 year to substances such as asbestos, radon, beryllium, chromium, cadmium, nickel, silicon, or soot, or e) first-degree relatives (parents, children, or siblings) diagnosed with lung cancer; and (3) willing and able to participate in the study. To limit confounding of study results, those with a previous history of cancer, or those with cognitive or psychological disorders (such as depression and anxiety), were excluded from the study. A flow chart of study enrollment is presented in Fig. 1.

Fig. 1.

Fig. 1

Study enrollment flow chart.

The sample size was calculated using the formula: N = [μα22 × π × (1–π)]/δ2, where the value of α represents the type I error (set at 0.05), and δ indicates the admissible error (set at 0.03).20 As determined by a previous study authored by Chen et al.,9 the LCS participation rate in China was 35.32% (π = 0.3532). By substituting each value into the sample size calculation formula, we obtained a required sample size of 975. Accounting for potential non-responses, a conservative estimate of a 20% non-response rate was assumed. Consequently, the minimum sample size for the study was calculated to be at least 1170 participants.

Survey instruments

Socio-demographic characteristics

Socio-demographic variables, including age, gender, body mass index (BMI), residential location, educational level, employment status, occupational exposure history, smoking status, family history of cancer, and other relevant characteristics were collected from participants.

Lung Cancer and Lung Cancer Screening Knowledge Questionnaire (Appendix 1)

The lung cancer and lung cancer screening knowledge questionnaire was adapted using peer-reviewed articles by Carter-Harris et al.,21,22 and was informed by the implementation plan of the survey of core knowledge of cancer prevention and control in Fujian Province.23 The questionnaire covered various aspects, including early symptoms of lung cancer, preventive measures, recommended groups for LCS, screening methods and frequency. It consisted of 9 items, including 4 single-item questions and 5 multiple-item questions. For single-answer questions, a correct response was assigned 1 point, while an incorrect answer received 0 points. For multiple-answer questions, a score of 2 points was given for a completely correct answer, and 0 points were assigned if the answer was partially correct or incorrect. A higher total score indicated a greater knowledge about lung cancer and LCS. In this study, the Cronbach's α coefficient for the overall scale was 0.89.

Stage of adoption algorithm: LCS (Appendix 2)

LCS behavior was evaluated using a stage of adoption algorithm adapted from an article by Carter-Harris et al.15 This algorithm consisted of 5 questions that corresponded to 7 stages of adoption. The 7 stages are, stage 1: unaware, stage 2: unengaged, stage 3: undecided, stage 4: decided not to act, stage 5: decided to act, stage 6: action, stage 7: maintenance. Individuals in stages 1 to 4 were considered as not participating in LCS, while individuals in stages 5 to 7 were considered as LCS participants.15

Lung Cancer Screening Health Belief Scales (Appendix 3)

The Lung Cancer Screening Health Belief scales were initially developed by Carter-Harris et al.,22 and translated and adapted by our research team. The questionnaire consisted of 35 items designed to assess individual health beliefs related to LCS and was organized into 4 subscales: perceived barriers to LCS (17 items), perceived benefits of LCS (6 items), perceived risk of lung cancer (3 items), and self-efficacy for LCS (9 items). Participants rated each item on a 4-point Likert scale. For subscales related to perceived benefits, perceived risks, and self-efficacy, positive items were scored from 1 to 4, while negative items in the perceived barriers subscale were scored from 4 to 1. A higher total score on each individual subscale indicated a stronger LCS health belief. The Cronbach's α coefficient ranged from 0.83 to 0.93 for the 4 subscales.

Cataldo Lung Cancer Stigma Scale (CLCSS) (Appendix 4)

Smoking-related stigma was evaluated using the smoking-related stigma subscale of Cataldo Lung Cancer Stigma Scale, which utilized a rating scale ranging from 1 to 4, where 1 indicated “strongly disagree” and 4 indicated “strongly agree.” Higher scores indicated a greater degree of smoking-related stigma. Others found the subscale demonstrated good internal consistency with a Cronbach's α coefficient of 0.80.24 The original subscale consisted of five items; however, for this study, the fourth item, “some people act as though it is my fault that I have lung cancer,” was deemed not applicable to high-risk individuals and was therefore excluded from the assessment. Consequently, the subscale used in this study was comprised of 4 items. In this study, the Cronbach's α coefficient for the overall scale was 0.85.

Generalized Anxiety Disorder Scale-7 (GAD-7) (Appendix 5)

The GAD-7 was initially developed by Spitzer et al.,25 and consists of 7 items that aim to assess the presence and severity of generalized anxiety symptoms experienced over the past two weeks. Participants rated each item on a 4-point Likert scale ranging from 0 to 3, with response options ranging from “not at all” to “nearly every day”. Higher scores indicated higher levels of anxiety. The Chinese version of the GAD-7 has previously demonstrated good internal consistency, with a Cronbach's α coefficient of 0.90.26

Patient Health Questionnaire-9 (PHQ-9) (Appendix 6)

The PHQ-9 was developed by Kroenke et al.,27 and consists of 9 items designed to assess the presence and severity of depressive symptoms experienced over the past two weeks. Participants rated each item on a 4-point Likert scale ranging from 0 to 3, with response options ranging from “not at all” to “nearly every day”. Higher scores indicated a higher level of depression severity. The Chinese version of the PHQ-9 has previously demonstrated good internal consistency, with a Cronbach's α coefficient of 0.83.28

Patient trust in the medical profession (Appendix 7)

Medical trust was evaluated using the Patient Trust in the Medical Profession Scale.29 This scale consisted of 5 items, and participants rated each item on a 5-point Likert scale ranging from 1 to 5. It is important to note that one of the items is negatively worded and is reverse-scored during analysis. The total score on the scale ranged from 5 to 25, with higher scores indicating a higher level of medical trust. The scale has demonstrated acceptable internal consistency, with a Cronbach's α coefficient of 0.77 in the past.29

Other indicators

Socio-environmental factors encompassed residential location, social influence, and media exposure. Social influence referred to the influence exerted by friends or family members. Media exposure included exposure to various sources, which may have influenced an individual's decision regarding early LCS, such as newspapers, magazines, television, broadcasts, the Internet, or brochures from the community or health departments. To evaluate the impact of these factors, the question was used “which sources of information would be helpful in making a decision regarding early LCS?” and was designed based on literature reviews.

Data collection

Data was collected through a pen-and-paper version of the questionnaires or online surveys, depending on participant preferences. Online surveys were administered through the Wenjuanxin online platform, a popular survey platform in China (available at https://www.wjx.cn).

Data analysis

Data analysis were conducted using SPSS 27.0 (IBM, Chicago, IL, USA). The significance level was predefined at P < 0.05 (2-tailed). Continuous variables were expressed as means with standard deviations (SD). Categorical variables were expressed as proportions or percentages. LCS behavior was used as the dependent variable (with a value of “0” representing “not participating in screening” and a value of “1” representing “participating in screening”), and statistically significant indicators from the univariate analysis were considered as independent variables. Binary logistic regression was performed to determine which influencing factors were associated with LCS behaviors.

Ethical considerations

The research was approved by the institutional review boards of Fujian Medical University (IRB No. FM2021097) and written informed consent was obtained from all participants.

Results

Participant characteristics

A total of 1652 high-risk individuals for lung cancer were included in this study. Among them, 909 (55.02%) were male and 743 (44.98%) were female, with a mean age of 63.92 years (SD = 6.65). The average BMI was 23.56 kg/m2 (SD = 2.91). Table 1 presents the socio-demographic characteristics of the participants.

Table 1.

Socio-demographic characteristics of participants (N = 1652).

Characteristic n (%)
Gender Male 909 (55.02)
Female 743 (44.98)
Residential location Urban 669 (40.50)
Rural 983 (59.50)
Religious belief No religion 530 (32.08)
Christianity 86 (5.21)
Buddhism 1009 (61.08)
Taoism 27 (1.63)
Educational level Primary school degree or below 669 (40.50)
Middle school degree 540 (32.69)
High school degree 366 (22.15)
Bachelor's degree or higher 77 (4.66)
Employment status Worker 72 (4.36)
Farmer 721 (43.64)
Administrative personnel 11 (0.67)
Science and technology, medical personnel or teacher 17 (1.03)
Individual, business, enterprise or service personnel 109 (6.60)
Retired 621 (37.59)
Homemaker 79 (4.78)
Othera 22 (1.33)
Occupational exposure historyb Yes 281 (17.01)
No 1371 (82.99)
Medical insurance type Self-paid (uninsured) 20 (1.21)
Publicly funded, free medical care 17 (1.03)
Urban employee basic medical insurance 552 (33.41)
Urban-rural basic medical insurance 1063 (64.35)
Monthly household income (yuan, RMB) < 1000 137 (8.29)
1000–3000 722 (43.70)
3001–5000 560 (33.90)
> 5000 233 (14.10)
Smoking status Non-smoker 887 (53.69)
Current smoker 587 (35.53)
Former smoker 178 (10.77)
Second-hand smoke exposure Yes 1171 (70.88)
No 481 (29.12)
History of COPD Yes 78 (4.72)
No 1574 (95.28)
Family history of lung cancer Yes 13 (0.79)
No 1639 (99.21)
Previous LCS behavior Yes
No
647 (39.16)
1005 (60.84)
Medical staff recommendation Yes
No
1386 (83.90)
266 (16.10)
Social influence Yes
No
1183 (71.61)
469 (28.39)
Media exposure Yes
No
958 (58.00)
694 (42.00)

COPD, chronic obstructive pulmonary disease; LCS, lung cancer screening.

a

Community service workers.

b

Such as asbestos, radon, beryllium, chromium, cadmium, nickel, silicon, soot.

Characteristics of LCS behaviors in high-risk individuals

Among the high-risk individuals, LCS behavior stages were largely reported as stage 1 and stage 2 (64.41%). Specifically, 1094 individuals (66.22%) were categorized as unaware (stage 1; 662), unengaged (stage 2; 402), or undecided (stage 3; 30) regarding LCS behavior. 110 individuals (stage 4; 6.66%) decided not to act, while 448 individuals (stages 5–7; 27.12%) were considered as LCS participants, which were categorized as decided to act (stage 5; 63), action (stage 6; 161), maintenance (stage 7; 224).

Univariate analysis of LCS behaviors in high-risk individuals

The results of the univariate analysis indicated that 20 factors, consisting of 9 continuous variables and 11 categorical variables, were found to be associated with LCS behavior (P < 0.05). These factors included age, lung cancer and its screening knowledge, medical trust, smoking-related stigma, LCS health beliefs, perceived barriers, perceived benefits, perceived risks, self-efficacy, residential location, religious beliefs, education level, occupation, medical insurance type, monthly average household income, smoking status, previous LCS behavior, medical staff recommendation, social influence, and media exposure. For detailed information on the univariate analysis results, please refer to Table 2, Table 3.

Table 2.

Univariate analysis of screening behaviors of high-risk individuals for lung cancer by continuous variable.

Variable LCS non-participant (n = 1204),
Mean ± SD
LCS participant (n = 448),
Mean ± SD
t/Z value P value
Age (years) 63.72 ± 6.64 64.47 ± 6.64 –2.024 0.043
Knowledge score 4.98 ± 2.95 7.46 ± 2.48 −17.090 < 0.001
Medical trust score 18.17 ± 3.00 19.26 ± 3.34 −6.359 < 0.001
Smoking-related stigma score 9.07 ± 2.13 8.63 ± 2.19 3.674 < 0.001
LCS health beliefs score 93.42 ± 7.99 102.24 ± 9.39 −17.644 < 0.001
Perceived barriers score 45.04 ± 5.79 48.92 ± 5.66 −12.319 < 0.001
Perceived benefits score
Perceived risks score
Self-efficacy score
17.74 ± 2.25
5.21 ± 1.93
25.43 ± 4.58
19.09 ± 2.82
5.51 ± 1.67
28.71 ± 4.68
−9.138
−3.122
−12.755
< 0.001
0.002
< 0.001

LCS, lung cancer screening.

Table 3.

Univariate analysis of screening behavior of high-risk individuals for lung cancer by categorical variable.

Variable LCS non-participant (n = 1204) LCS participant (n = 448) χ2 P value

Residential location Urban 420 249 −2.024 0.043
Rural 784 199
Religious belief No religion 341 189 46.497 < 0.001
Christianity 53 33
Buddhism 783 226
Taoism 27 0
Educational level Primary school degree or below 550 119 97.898 < 0.001
Middle school degree 406 134
High school degree 211 155
Bachelor's degree or higher 37 40
Employment status Worker 62 10 133.679 < 0.001
Farmer 608 113
Administrative personnel 5 6
Science and technology, medical personnel or teacher 7 10
Individual, business, enterprise or service personnel 72 37
Retired 367 254
Homemaker 65 14
Othera 18 4
Medical insurance type Self-paid (uninsured) 14 6 78.955 < 0.001
Publicly funded, free medical care 11 6
Urban employee basic medical insurance 328 224
Urban-rural basic medical insurance 851 212
Monthly household income (yuan, RMB) < 1000 110 27 104.747 < 0.001
1000–3000 599 123
3001–5000 375 185
> 5000 120 113
Smoking status Non-smoker 637 250 10.502 0.005
Current smoker 451 136
Former smoker 116 62
Previous LCS behavior Yes
No
278
926
369
79
481.512 < 0.001
Medical staff recommendation Yes
No
986
218
400
48
13.207 < 0.001
Social influence Yes
No
832
372
351
97
13.728 < 0.001
Media exposure Yes
No
135
559
313
645
35.586 < 0.001

LCS, lung cancer screening.

a

Community service workers.

Binary logistic regression analysis of LCS behaviors in high-risk individuals

As shown in Table 4, several factors acted as facilitators of LCS, including urban residence (OR = 1.717, 95% CI: 1.224–2.408), holding administrative positions (OR = 16.601, 95% CI: 2.118–130.126), previous LCS behavior (OR = 10.331, 95% CI: 7.463–14.302), media exposure focused on LCS (OR = 1.868, 95% CI: 1.344–2.596), high level of knowledge about lung cancer and LCS (OR = 1.256, 95% CI: 1.185–1.332), perceived risks of lung cancer (OR = 1.123, 95% CI: 1.029–1.225), and LCS health beliefs (OR = 1.090, 95% CI: 1.067–1.113). The sole barrier to LCS was identified as social influence (OR = 0.669, 95% CI: 0.465–0.964).

Table 4.

Select logistic regression analysis results of screening behavior of high-risk individuals for lung cancer.

Variable B S.E. Wald OR (95% CI) P value
Constant −13.894 1.288 116.341 < 0.001
Residential location (rural as reference)
 Urban 0.540 0.173 9.810 1.717 (1.224–2.408) 0.002
Employment status (other as reference)
 Administrative personnel 2.809 1.051 7.152 16.601 (2.118–130.126) 0.007
Previous LCS behavior 2.335 0.166 198.020 10.331 (7.463–14.302) < 0.001
Social influence −0.402 0.186 4.658 0.669 (0.465–0.964) 0.031
Media exposure 0.625 0.168 13.830 1.868 (1.344–2.596) < 0.001
Knowledge score 0.228 0.030 58.495 1.256 (1.185–1.332) < 0.001
Perceived risk score 0.116 0.045 6.805 1.123 (1.029–1.225) 0.009
LCS health beliefs score 0.086 0.011 63.083 1.090 (1.067–1.113) < 0.001

S.E, standard error; OR, odds ratio; CI, confidence interval; LCS, lung cancer screening. Model χ2 = 766.339 (P < 0.001), Nagelkerke R2 = 0.538.

Discussion

This study provides a scientific basis for future development of LCS intervention programs that enhance awareness and beliefs of screening and aim to improve screening behaviors in high-risk groups. It also helps to emphasize the importance of early prevention of cancer, which is clinically and practically important to improve the prognosis of high-risk individuals for lung cancer, as well as reduce the morbidity and mortality rates of lung cancer.

Current status of LCS behaviors among high-risk individuals

The screening behavior stages of 1652 high-risk individuals were predominantly concentrated in Stages 1 and 2, and accounted for 64.4% of the total sample. Findings indicated that over half of the high-risk individuals were either unaware of, or unengaged, with LDCT screenings. This suggested that a significant proportion of these individuals had not heard of LDCT, or lacked the motivation to undergo screening, even if they were aware of its existence.

The number of individuals adhering to annual LDCT screenings was 224, which only represented 13.6% of the total sample. This finding is particularly concerning as lung cancer has the highest reported incidence and mortality rates in malignant tumor registries of Fujian Province.30 The annual screening participation rate in this study was far below that reported in the United States (45.0% to 55.0%).31 These findings strongly suggest that a substantial disparity exists in screening behaviors among high-risk individuals when compared to other regions of China. The notably lower screening participation rate observed in this study may be due to insufficient promotion of LCS by the relevant health authorities and lack of proactive awareness of LCS and screening-related health knowledge among high-risk individuals, which emphasizes the need for targeted interventions and awareness campaigns to improve the uptake of LDCT screenings in this particular population. Such interventions may include conducting motivational interviews and lectures, as well as distributing educational brochures and other printed materials. Addressing these disparities is crucial to enhancing early detection and reducing the burden of lung cancer in high-risk individuals across the country.

Factors related to LCS behaviors among high-risk individuals

In line with previous studies,17,32, 33, 34, 35 we found that individuals who had previously undergone LCS, and those who were exposed to media coverage focused on LCS, tended to have higher levels of knowledge about lung cancer and LCS as well as higher perceived risks of lung cancer and stronger LCS health beliefs. Consequently, these individuals were more actively involved in LCS. Regarding previous LCS behaviors, the likely reason for this association is that screened high-risk individuals had a clearer understanding of LDCT screening methods and procedures, which reduced their reluctance to engage in future LCS. Additionally, positive screening experiences could have increased their confidence and motivation to maintain good LCS behaviors.36

Unlike previous research,16,37 this study demonstrated that social influence negatively affected LCS behaviors among high-risk individuals. Advice received from family and friends may be less credible than that from health care providers, and the low cognitive levels of the participants may have hindered the impact of social influence on their beliefs about LCS benefits. However, media exposure through various channels, coupled with higher knowledge levels about lung cancer and LCS, have proved effective in promoting LCS behaviors. Sharing LCS knowledge through social media has subtly influenced attitudes and encouraged individuals to prioritize their health.37 To improve screening initiatives, medical departments should target individuals with limited knowledge and design tailored publicity programs. Strategic utilization of media exposure can amplify health-centric ideas and drive positive health behavior changes among high-risk individuals.

Our findings demonstrate that higher perceived risks of lung cancer and LCS health beliefs can promote LCS behaviors among high-risk individuals. These results align with the findings of most studies.23,36 Regarding perceived risks, related research has shown that high-risk individuals with a greater perceived risk of lung cancer tend to have positive beliefs about LDCT and health-related behaviors.38 This may be attributed to high-risk individuals being more aware of their own risks and wanting to stay informed about their true health status, thereby improving their compliance with screenings. However, the findings of Ali et al.,39 also revealed that a higher perceived risk of lung cancer may create psychological burden in high-risk individuals, potentially hindering LCS behaviors. Conclusions about perceived risks of lung cancer are inconsistent, possibly due to variations in individuals’ understanding of their own risk, leading to different screening outcomes.

LCS health beliefs are an essential factor that influences one's willingness to participate in LCS.22 High-risk individuals with stronger LCS health beliefs can better understand the susceptibility and seriousness of lung cancer, thus promoting the maintenance of active LCS behaviors.40 In the future, targeted publicity and educational programs may be formulated based on individuals' LCS health belief levels to enhance the understanding of lung cancer. This, in turn, will promote a conscious adoption of LCS behaviors and improve preventive awareness.

The findings regarding occupation revealed that individuals holding administrative positions were more actively involved in LCS, possibly due to better financial status and access to medical treatment, reducing their health care burden. Their involvement in health-related work and cooperation with the government also played a role in motivating them to participate in LCS.38 Regarding residential location, urban residents showed higher LCS participation rates due to better transportation and health care resources, as well as increased awareness from stronger publicity in cities.17 However, conflicting results from other studies showed that the effect of residential location on LCS behavior remains uncertain.22

Implications for nursing practice and research

Comprehending the current state of LCS behaviors and their influencing factors has provided scientific evidence to guide the development of targeted interventions. These interventions aim to assist individuals at high risk of lung cancer in making informed decisions about screening, raising awareness and beliefs regarding LCS, and improving their LCS behaviors. Furthermore, identifying the influencing factors of LCS in high-risk individuals informs future research aimed at promoting targeted interventions for LCS behaviors.

Limitations

Several limitations of this study should be considered. First, the study only recruited participants from Fujian Province in China due to constraints in manpower, material resources, and time. Consequently, the generalization of the findings to other regions of China may be influenced. Future research should encompass a more diverse sample throughout China to enhance the study's external validity. Second, this study employed a cross-sectional design with no follow-up data collected. To gain a deeper understanding of the dynamic changes in LCS behaviors among high-risk individuals, multi-center, longitudinal studies are needed. Such studies will provide a stronger theoretical basis for implementing effective LCS interventions. Third, in order to facilitate a larger sample size, data collection was conducted through both a pen-and-paper version of the questionnaires and online version, which may have introduced variability in the study results. For future studies, a single data collection method is recommended.

Conclusions

This study highlights the persistently low participation rate of LCS in Fujian Province in China. Among high-risk individuals, certain factors were found to be associated with a higher willingness to undergo LCS. These factors included urban residence, holding administrative positions, previous LCS behavior, media exposure focused on LCS, higher levels of knowledge about lung cancer and LCS, higher risk perceptions of lung cancer, and stronger LCS health beliefs. However, social influence was identified as a barrier to LCS participation. These findings underscore the need for early interventions targeted at addressing these specific factors to enhance disease prevention efforts and promote the importance of participating in LCS to individuals. Earlier diagnosis and treatment of lung cancer will ultimately lead to reductions in health care burdens to individuals and society.

Ethics statement

The research was approved by the institutional review boards of Fujian Medical University (IRB No. FM2021097) and written informed consent was obtained from all participants.

Funding

This study was supported by National Natural Science Foundation of China (Grant No. 72304068); General Project of Fujian Provincial Nature Science Foundation (Grant No. 2021J01246). The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.

CRediT authorship contribution statement

Yu-An Lin: Formal analysis, Writing-Original draft. Yong Lin Li: Writing, editing. Xiu Jing Lin: Data collection. Fang Fang Wang: Writing, editing. Rachel Arbing: Writing editing. Wei-Ti Chen: Methodology, Writing-Supervision. Fei Fei Huang: Conceptualization, Methodology, Writing-Reviewing and Supervision. All authors had full access to all the data in the study, and the corresponding author had final responsibility for the decision to submit for publication. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.

Declaration of competing interest

All authors have no conflicts of interest to declare. The corresponding author, Professor Feifei Huang, is a member of the editorial board of the Asia-Pacific Journal of Oncology Nursing. The article underwent the journal's standard review procedures, with peer review conducted independently of Professor Huang and their research groups.

Acknowledgments

We expressed our full gratitude to all the study participants, without them, it is not possible to complete this study. We also would like to thank Ms. Rachel Arbing for English language editing.

Data availability statement

The data that support the findings of this study are available from the corresponding author Feifei Huang, upon reasonable request.

Declaration of Generative AI and AI-assisted technologies in the writing process

No AI tools/services were used during the preparation of this work.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.apjon.2024.100402.

Appendix A. Supplementary data

The following is/are the supplementary data to this article.

Multimedia component 1
mmc1.docx (27.3KB, docx)

References

  • 1.Sung H., Ferlay J., Siegel R.L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660. [DOI] [PubMed] [Google Scholar]
  • 2.Liu Z.C., Li Z.X., Zhang Y. Interpretation on the report of global cancer statistics 2020. Journal of Multidisciplinary Cancer Management (Electronic Version) 2021;7(2):1–14. doi: 10.12151/JMCM.2021.02-01. [DOI] [Google Scholar]
  • 3.Jin F.G. The present situation of early screening of lung cancer in China. Med Philosophy. 2017;38(2):14–18. doi: 10.12014/j.issn.1002-0772.2017.01b.04. [DOI] [Google Scholar]
  • 4.Oncology Society of Chinese Medical Association, Chinese Medical Association Publishing House Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2021 edition) Chin J Oncol. 2021;43(6):591–621. doi: 10.3760/cma.j.cn112152-20210207-00118. [DOI] [PubMed] [Google Scholar]
  • 5.National Lung Screening Trial Research Team. Aberle D.R., Adams A.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. doi: 10.1056/NEJMoa1102873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Li N., Tan F., Chen W., et al. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study. Lancet Respir Med. 2022;10(4):378–391. doi: 10.1016/S2213-2600(21)00560-9. [DOI] [PubMed] [Google Scholar]
  • 7.Jemal A., Fedewa S.A. Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015. JAMA Oncol. 2017;3(9):1278–1281. doi: 10.1001/jamaoncol.2016.6416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Triplette M., Thayer J.H., Pipavath S.N., Crothers K. Poor uptake of lung cancer screening: opportunities for improvement. J Am Coll Radiol. 2019;16(4 Pt A):446–450. doi: 10.1016/j.jacr.2018.12.018. [DOI] [PubMed] [Google Scholar]
  • 9.Chen W.Q., Li N., Cao M.M. Preliminary analysis of cancer screening program in urban China from 2013 to 2017. China Cancer. 2020;29(1):1–6. doi: 10.11735/j.issn.1004-0242.2020.01.A001. [DOI] [Google Scholar]
  • 10.Guo L.W., Liu S.Z., Zhang S.K., et al. 2013-2017 Low dose spiral CT screening screen for lung cancer in urban areas of Henan Province Check effect analysis. China Cancer. 2020;42(2):155–159. doi: 10.3760/cma.j.issn.0253-3766.2020.02.013. [DOI] [PubMed] [Google Scholar]
  • 11.Wen Y., Yu L.Z., Du L.B., et al. Analysis of low-dose computed tomography compliance and related factors among high-risk population of lung cancer in three provinces participating in the cancer screening program in urban China. Chin J Prev Med. 2021;55(5):633–639. doi: 10.3760/cma.j.cn112150-20201015-01286. [DOI] [PubMed] [Google Scholar]
  • 12.Cao W., Tan F., Liu K., et al. Uptake of lung cancer screening with low-dose computed tomography in China: a multi-centre population-based study. EClinicalMedicine. 2022;52 doi: 10.1016/j.eclinm.2022.101594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Healthy China Initiative Promotion Committee Healthy China initiative (2019–2030): overall requirements, major actions and main indicators. Chinese Circulation Journal. 2019;34(9):846–858. doi: 10.3969/j.issn.1000-3614.2019.09.003. [DOI] [Google Scholar]
  • 14.Lin Y.A., Hong Y.T., Lin X.J., et al. Barriers and facilitators to uptake of lung cancer screening: a mixed methods systematic review. Lung Cancer. 2022;172:9–18. doi: 10.1016/j.lungcan.2022.07.022. [DOI] [PubMed] [Google Scholar]
  • 15.Carter-Harris L., Slaven J.E., 2nd, Monahan P.O., et al. Understanding lung cancer screening behaviour using path analysis. J Med Screen. 2020;27(2):105–112. doi: 10.1177/0969141319876961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Schiffelbein J.E., Carluzzo K.L., Hasson R.M., et al. Barriers, facilitators, and suggested interventions for lung cancer screening among a rural screening-eligible population. J Prim Care Community Health. 2020;11 doi: 10.1177/2150132720930544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Bui N.C., Lee Y.Y., Suh M., et al. Beliefs and intentions to undergo lung cancer screening among Korean males. Cancer Res Treat. 2018;50(4):1096–1105. doi: 10.4143/crt.2017.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.He J., Li N., Chen W.Q., et al. China guideline for the screening and early detection of lung cancer (2021, Beijing) Chinese J Oncol. 2021;30(2):81–111. doi: 10.11735/j.issn.1004-0242.2021.02.A001. [DOI] [PubMed] [Google Scholar]
  • 19.von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi: 10.1016/S0140-6736(07)61602-X. [DOI] [PubMed] [Google Scholar]
  • 20.Hajian-Tilaki K. Sample size estimation in epidemiologic studies. Caspian J Intern Med. 2011;2(4):289–298. PMID: 24551434. [PMC free article] [PubMed] [Google Scholar]
  • 21.Carter-Harris L., Slaven J.E., Jr., Monahan P.O., Shedd-Steele R., Hanna N., Rawl S.M. Understanding lung cancer screening behavior: racial, gender, and geographic differences among Indiana long-term smokers. Prev Med Rep. 2018;10:49–54. doi: 10.1016/j.pmedr.2018.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Carter-Harris L., Slaven J.E., 2nd, Monohan P., Rawl S.M. Development and psychometric evaluation of the lung cancer screening health belief scales. Cancer Nurs. 2017;40(3):237–244. doi: 10.1097/NCC.0000000000000386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.People's Government of Gulou District, Fuzhou City. Notice of Gulou district Center for Disease Control and Prevention on forwarding the implementation plan of the survey of core knowledge of cancer prevention and control in Fujian Province. http://www.gl.gov.cn/xjwz/zfxxgk/qzbmptlj/qzfqtjgsydw/glqjkzx/fdzdgknr/qt/202110/t20211015_4206598.htm. Accessed December, 2021.
  • 24.Cataldo J.K., Slaughter R., Jahan T.M., Pongquan V.L., Hwang W.J. Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scale. Oncol Nurs Forum. 2011;38(1):E46–E54. doi: 10.1188/11.ONF.E46-E54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Spitzer R.L., Kroenke K., Williams J.B., Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi: 10.1001/archinte.166.10.1092. [DOI] [PubMed] [Google Scholar]
  • 26.He X.Y., Li C.B., Qian J. Reliability and validity of a generalized anxiety disorder scale in general hospital outpatients. Shanghai Arch Psychiatry. 2010;22(4):200–203. doi: 10.3969/j.issn.1002-0829.2010.04.002. [DOI] [Google Scholar]
  • 27.Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Xu Y., Wu H.S., Xu Y.F. The reliability and validity of patient health questionnaire depression module (PHQ-9) in Chinese elderly. Shanghai Arch Psychiatry. 2007;19(5):257–259. doi: 10.3969/j.issn.1002-0829.2007.05.001. 276. [DOI] [Google Scholar]
  • 29.Dugan E., Trachtenberg F., Hall M.A. Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res. 2005;5:64. doi: 10.1186/1472-6963-5-64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ma J.Y., Zhou Y., Lin Y.T. Analysis of incidence and mortality in Fujian cancer registries, 2016. China Cancer. 2021;30(4):241–249. doi: 10.11735/j.issn.1004-0242.2021.04.A001. [DOI] [Google Scholar]
  • 31.Lin Y., Fu M., Ding R., et al. Patient adherence to lung CT screening reporting & data system-recommended screening intervals in the United States: a systematic review and meta-analysis. J Thorac Oncol. 2022;17(1):38–55. doi: 10.1016/j.jtho.2021.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Holman A., Kross E., Crothers K., et al. Patient perspectives on longitudinal adherence to lung cancer screening. Chest. 2022;162(1):230–241. doi: 10.1016/j.chest.2022.01.054. [DOI] [PubMed] [Google Scholar]
  • 33.Williams R.M., Beck K.H., Butler J., 3rd, et al. Lung cancer screening decisional needs among African American smokers of lower socioeconomic status. Ethn Health. 2022;27(3):565–583. doi: 10.1080/13557858.2020.1771681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lu M.M., Zhang T., Zhao L.H., et al. The relationship between demands for lung cancer screening and the constructs of health belief model: a cross-sectional survey in Hefei, China. Psychol Health Med. 2018;23(8):934–951. doi: 10.1080/13548506.2018.1428757. [DOI] [PubMed] [Google Scholar]
  • 35.Raz D.J., Wu G., Nelson R.A., et al. Perceptions and utilization of lung cancer screening among smokers enrolled in a tobacco cessation program. Clin Lung Cancer. 2019;20(1):e115–e122. doi: 10.1016/j.cllc.2018.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lei F., Chen W.T., Brecht M.L., et al. Health beliefs toward lung cancer screening among Chinese American high-risk smokers: interviews based on health belief model. Int J Nurs Sci. 2022;9(3):378–388. doi: 10.1016/j.ijnss.2022.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Couraud S., Greillier L., Brignoli-Guibaudet L., et al. Current and former smokers: who wants to be screened? Clin Lung Cancer. 2018;19(6):493–501. doi: 10.1016/j.cllc.2018.07.001. [DOI] [PubMed] [Google Scholar]
  • 38.Chen J. China University of Geosciences; Beijing: 2020. Study on Influencing Factors of Participation in Screening of “two cancers” in Women in SF Township. MS Thesis. [DOI] [Google Scholar]
  • 39.Ali N., Lifford K.J., Carter B., et al. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ Open. 2015;5(7) doi: 10.1136/bmjopen-2015-008254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Li X.H. Application of the health belief model in nursing practice. Cont Med Educ. 2006;20(29):21–24. doi: 10.3969/j.issn.1004-6763.2006.29.007. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.docx (27.3KB, docx)

Data Availability Statement

The data that support the findings of this study are available from the corresponding author Feifei Huang, upon reasonable request.


Articles from Asia-Pacific Journal of Oncology Nursing are provided here courtesy of Elsevier

RESOURCES